Health Promoting Work Schedules: The Effect of Abolishing Quick Returns (HeWoS)

Towards a Sustainable Work Force in the Healthcare Sector for the 21st Century: Health-promoting Work Schedules (HeWoS)

Introduction In shift work, quick returns refer to transitions between two shifts with less than 11 hours available rest time. Twenty-three per cent of employees in European countries reported having quick returns. Quick returns are related to short sleep duration, fatigue, sleepiness, work-related accidents, and sickness absence. The present study is the first randomized controlled trial (RCT) to investigate the effect of a work schedule without quick returns for six months, compared to a work schedule that maintains quick returns during the same time frame.

Methods and analysis A parallel-group cluster RCT in a target sample of more than 4000 healthcare workers at Haukeland University Hospital in Norway will be conducted. More than 70 hospital units will be assessed for eligibility and randomized to a work schedule without quick returns for six months or continue with a schedule that maintains quick returns. The primary outcome is objective records of sickness absence; secondary outcomes are questionnaire data (n ≈ 4000 invited) on sleep and functioning, physical and psychological health, work-related accidents, and turnover intention. For a subsample, sleep diaries and objective sleep registrations with radar technology (n ≈ 50) will be collected.

Ethics and dissemination The study protocol was approved by the Regional Committee for Medical and Health Research Ethics in Western Norway (2020/200386). Findings from the trial will be disseminated in peer-reviewed journals and presented at national and international conferences. Exploratory analyses of potential mediators and moderators will be reported. User-friendly outputs will be disseminated to relevant stakeholders, unions and other relevant societal groups.

Study Overview

• Status: Recruiting
• Conditions: Fatigue; Insomnia; Health, Subjective; Psychological Distress; Shift-Work Sleep Disorder; Sick Leave; Work Accident; Turnover Intention; Work-family Spillover
• Intervention / Treatment: Other: Shift schedule without quick returns

Detailed Description

Aims This is a two-arm cluster randomized controlled trial that assesses the consequences of a shift work schedule without quick returns for six months, compared to a schedule that include quick returns. First, we will examine any differential change in sickness absence, during the six-month intervention period. Second, we will examine if there are differential changes in sleep and functioning, physical and mental health, work-related accidents, and turnover intention, among others. Third, we will investigate if individual characteristics associated with shift work tolerance including sex, age, personality and subjectively reported sleep need will moderate the negative effects of quick returns on the primary and secondary outcomes. Finally, the study will investigate if individual factors like satisfaction with work schedule, job satisfaction, job engagement and work-family interference will moderate the negative effects of quick returns on the primary and secondary outcomes.

Research design A cluster randomized controlled trial comparing a work schedule abolishing quick returns (intervention) with that of a work schedule maintaining a normal amount of quick returns (control) will be conducted. The clusters represent hospital units that are randomly selected to receive (or not receive) the intervention. 'Normal amount of quick returns' refer to that which is the common practice at the respective hospital unit in recent years (i.e., when no explicit changes have been made to the work schedule), which means that the total number of quick returns at the unit will vary from 329-2356 per year. The hospital units were randomized to one of the two conditions in September 2020, of which the autumn of 2020 was spent planning the shift schedule for 2021 (i.e., removing quick returns for the intervention group and leaving quick returns untouched for the control group), with the intervention period commencing from February/March 2021 for most units. The intervention period in this study is six calendar months. Most units in this trial start the intervention period in February/March 2021, but some units will, for practical reasons, start the intervention period in the second half of the rotation year, i.e. from August/September 2021 or later.

The primary outcome is sickness absence retrieved from the local records kept by the hospital (including short- and long-term sick leave). The baseline measurements will be sickness absence from the year preceding the intervention, which for each individual participant will be matched on duration and season to that of the intervention period. Sickness absence data will be retrieved from the local records kept by the hospital (Vedaa, Pallesen et al. 2017). This record includes information about the date of any absence of the individual employee, implying that it includes information about both short- and long-term sickness absence. Further, these data include information on whether the absence is self-certified or whether it is certified by a physician, whether the absence is due to a sick child of whom the employee has caretaker responsibility of, and whether the absence is due to COVID-19 related issues (e.g., quarantine). The use of register data will not require individual consent. However, a consent-based part of the trial will also be conducted, in which secondary outcome measures will be collected via questionnaire at baseline and six-month follow-up. All employees (n ≈ 4000) at the randomized units will be asked to complete a digital questionnaire made available via the hospital's internal website. Baseline assessment will occur prior to the intervention period, and follow-up assessment will occur towards the end of the intervention period. A subsample (n ≈ 50) will be asked to objectively record their sleep with advanced radar technomogy (Somnofy™) and subjectively with sleep diaries for ≥1 week at the baseline and follow-up assessments, respectively.

Participants and procedure Recruitment This trial is carried out in close collaboration with the human resources department at Haukeland University Hospital. All hospital care units that have 24-hour staffing at the hospital will be randomized, in which all healthcare workers working shifts will be included, with the exception of physicians. Physicians will not be included since they often have a different shift schedule and compensation scheme compared to the other occupational groups. Hereinafter, 'all employees' refer to all healthcare workers engaged in shift work at the randomised hospital units, with the exception of physicians. All employees (n ≈ 4000) at the randomized hospital units will be asked to complete a questionnaire prior to and at the end of the intervention period. Recruitment for this part of the trial will take place via the hospital's internal website. Researchers and human resources personnel at the hospital will attend staff meetings at all included units to inform about the research project and encourage participation. A subsample of n ≈ 50 randomly selected employees (evenly distributed from the intervention and the control units) will be recruited for the sleep monitoring section of the trial.

Randomisation and masking The randomization in this trial occurred at the cluster level, in which hospital units constituted the clusters. Hospital units can vary in terms of how much staff they need over the 24-hour day, hence, the work schedule and the occurrence of, for example, quick returns and night shifts can vary across the units. Similar units were therefore grouped together based on the fact that they shared some attributes or characteristics. Then a stratified randomization was performed to the two study conditions in a 1: 1 ratio. One subgroup could, for example, consist of units with emergency functions, another with intensive care functions, one with mental health care, and one with maternity care, etc. In total we had 10 strata and the sizes of each stratum varied between 2 and 19 hospital units. The randomization list for each stratum was generated by the online randomization webpage, www.randomization.com, and the list for each stratum was saved.

It is not possible for participants to be blinded to the group to which they are assigned. However, statistical analyses will be done by a researcher who is masked to group allocation.

Sample size In this trial, all available hospital units at Haukeland University Hospital with healthcare workers who work rotating shifts will be assessed for eligibility. This includes 76 units and 4260 healthcare workers. Based on previous published data5 we have calculated that a total of 2028 participants is sufficient to reveal a difference in days of sick leave of 0.9 and 1.25 with an ICC of 0.1 and an average size of the units of 52 (calculation made in: StataCorp. 2015).33 Thus, with the planned recruitment strategy (i.e., invite >70 units and >4000 healthcare workers) we expect to exceed this number and be well within the number of participants required for the primary outcome variable.

Data analysis plan All analyses will be conducted based on the intention-to-treat population, unless otherwise stated. To examine the effects of a shift schedule abated of quick returns on primary and secondary outcomes, the observed rates or scores will be analysed by means of latent growth models (or other equivalent models such as generalized linear mixed models). The observed rates or scores before and during the intervention period will be modelled by a random intercept and a fixed slope. The effect of the intervention will be estimated by using the group variable (intervention vs. control) as a predictor of the slope. Between-group effect sizes (Cohen's d) will be calculated by dividing the mean difference in estimated change in scores from baseline to the follow-up assessment by the pooled SD at baseline. Robust maximum likelihood will be used as the estimator, providing unbiased estimates under the assumption of data being missing at random,(Enders 2010) which might be partly met through the inclusion of baseline scores to the model. The primary outcome measure in this trial is sickness absence data retrieved from the register at the hospital, in which we expect no missing data. However, it is reasonable to expect some missing data on the secondary outcome measures, as data are collected through questionnaire or via the sleep radar.

As some data for the follow-up questionnaire and sleep radar assessment will be missing not at random, the robustness of the results under the missing-at-random assumption will be tested by sensitivity analyses in which the missing scores at follow-up will be replaced by baseline values for each respective individual. These sensitivity analyses will only be performed on selected variables depending on the focus in the respective article.

The intention-to-treat analyses may be accompanied by selected per-protocol analyses in which we, based on payroll data, define a group that has completely abolished or had a satisfactory reduction in the number of quick returns over the intervention period.

The primary outcome of sick leave will mainly be analysed in terms of the total number of sickness absence days and periods (spells) for a given period before compared to during the intervention period (Vedaa, Pallesen et al. 2017). The models of sickness absence will take into account the zero inflation in this type of data. Other operationalisations of sickness absence might also be considered in accordance with recommendations in the literature (Hensing, Alexanderson et al. 1998). For a further investigation of the sickness absence data, we will consider the use of other models where we treat time differently. For example, we will consider models where we look at the time to the first sick leave episode for the two intervention groups, with a time-dependent covariate for the number of quick returns (ie, a variable that increases by 1 each time the person has a quick return). Another possibility is to say that participants start at "0" every time the person has a quick return, and to measure time from the last quick return to the first subsequent sick leave episode, while adjusting for repeated observations with e.g. robust variance estimate (the non-quick return group will then only be followed from the start of the intervention, given that they in fact have no quick returns). Another option is to set up a model for time from sick leave to return to work.

Since the introduction of a work schedule without quick returns may entail an alternative schedule with an increase in other undesirable characteristics (e.g., more consecutive evening shifts), we will consider conducting analyses that adjust for such characteristics.

Mediator and moderator analyses will be performed for exploratory purposes, based on the basic principle for such analyses in randomised controlled trials as described by others ((e.g., Kraemer, Wilson et al. 2002)). For example, some of the data collected on demographics, sleep-related personality traits (rCTI and MEQ), mental health, among others, can be used to examine factors that may moderate the impact of the intervention.

References

Enders, C. K. (2010). Applied missing data analysis. New York, NY, US, Guilford Press.

Hensing, G., et al. (1998). "How to measure sickness absence? Literature review and suggestion of five basic measures." Scandinavian journal of public health 26: 133-144.

Kraemer, H. C., et al. (2002). "Mediators and moderators of treatment effects in randomized clinical trials." Archives of General Psychiatry 59: 877-883.

Vedaa, Ø., et al. (2017). "Short rest between shift intervals increases the risk of sick leave: a prospective registry study." Occupational and Environmental Medicine 74: 496-501.

• Study Type: Interventional
• Enrollment (Anticipated): 2700
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Anette Harris, PhD; Phone Number: +47 55 58 32 19; Email: anette.harris@uib.no
• Study Contact Backup: Name: Øystein Vedaa, PhD; Phone Number: +47 21 07 88 34; Email: oystein.vedaa@fhi.no

Study Locations

• Norway
  • Vestland
    • Bergen, Vestland, Norway, 5015
      • Recruiting
      • Haukeland University Hospital
      • Contact: Erling Svensen, PhD, PsyD; Email: erling.svensen@helse-bergen.no

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• The unit-level inclusion criteria are that the units should have: 1) healthcare workers (other than physicians) who work rotating shifts, 2) employees who regularly have quick returns in their work schedule, and 3) a new shift rotation year commencing from February/March 2021 (which is the case for most units at Haukeland University Hospital).
• Employees must be healthcare workers at the above-mentioned hospital units.
• Employees must have >50% position.

Exclusion Criteria:

• Exclusion criteria at the unit-level are 1) units have recently (or will in the near future) went through other major organizational changes that may confound the results (this includes during the period from one year before the intervention starts until the intervention period is over) of the trial, or 2) unit's manager or a substantial number of employees strongly oppose participation in the trial.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: With quick returns; The control condition in this trial implies that employees maintain the same number of quick returns as in previous years for the six-month intervention period. Hospital units in the control group are not expected to experience any increase in the number of quick returns.
Experimental: Without quick returns; The intervention entails implementing a shift schedule which abolishes quick returns for a six-month intervention period. The number of quick returns in the various hospital units in this trial varies from 329-2356 per year. The intervention means that this number is abolished or reduced as much as possible. For practical reasons it is reasonable to expect that for many of the units it may be a matter of reducing rather than completely abolishing quick returns, as ensuring adequate staffing (e.g., due to sickness absence), often on short-notice make it impossible to comply with the rule of avoiding quick returns. The human resources department at the hospital assisted shift planners in scheduling shift schedules without quick returns.	Other: Shift schedule without quick returns; The intervention entails implementing a shift schedule which abolishes or substantially reduces the number of quick returns (less than 11 hours of rest between two shifts) for a six-month intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sickness absence	Sickness absence data will be retrieved from the local register at the hospital. Sickness absence will mainly be analysed in terms of the total number of sickness absence days and periods (spells) for a given period before compared to during the intervention period.	For example, sickness absence in the last three months of the intervention period will be compared with three months the year before the intervention started, matched in terms of season.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Insomnia	The Bergen Insomnia Scale	Questionnaires are answered before and towards the end of the six-month intervention period
Shift work disorder	Shift work disorder will be measured with three standardised questions	Questionnaires are answered before and towards the end of the six-month intervention period
Fatigue	The Swedish Occupational Fatigue Inventory	Questionnaires are answered before and towards the end of the six-month intervention period
Job satisfaction	Job satisfaction will be assessed with five items (e.g., "I find real enjoyment in my work") from the Job Satisfaction Index	Questionnaires are answered before and towards the end of the six-month intervention period
Mental Health	Hopkins symptom checklist - 5	Questionnaires are answered before and towards the end of the six-month intervention period
Work-family spillover	The Work family Interface Scale developed by Kinnunen, Feldt, Geurts et al. will be used to evaluate the four types of work-family spillover	Questionnaires are answered before and towards the end of the six-month intervention period
Work-related negative incidents	Work-related negative incidents will be assessed using eight items measuring the number of self-reported work-related accidents, near accidents and dozing off at work or while driving to or from work.	Questionnaires are answered before and towards the end of the six-month intervention period
Turnover Intention	The Turnover Intention Scale will be measured with the three-item Turnover Intention Scale adapted from Michigan Organizational Assessment Questionnaire	Questionnaires are answered before and towards the end of the six-month intervention period
Sleep (subjective and objective)	Will be measured subjectively with a sleep diary and objectively with a Xethru sensor, a low-powered ultra-wideband radar.	Sleep is measured with a sleep diary and sleep radar for >7 days before and towards the end of the six-month intervention period.
Subjective health complaints	Subjective health complaints inventory (only parts of the scale will be used)	Questionnaires are answered before and towards the end of the six-month intervention period

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Unwanted / negative effects	We will measure if changed work schedule has led to disturbed sleep, more stress, worry, depression, overall less time for recovery between work periods, problems in work-family balance, disrupted social relationships, poorer psychosocial climate at work, experience of reduced quality of care offered to patients, etc.	Possible negative outcomes of the intervention will be measured after the intervention period.

Collaborators and Investigators

• Sponsor: Norwegian Institute of Public Health
• Collaborators: University of Bergen
• Investigators: Principal Investigator: Anette Harris, PhD, University of Bergen, Norway

Publications and helpful links

General Publications

• Vedaa O, Djupedal ILR, Svensen E, Waage S, Bjorvatn B, Pallesen S, Lie SA, Nielsen M, Harris A. Health-promoting work schedules: protocol for a large-scale cluster randomised controlled trial on the effects of a work schedule without quick returns on sickness absence among healthcare workers. BMJ Open. 2022 Apr 15;12(4):e058309. doi: 10.1136/bmjopen-2021-058309.

Helpful Links

• Link to information letter to participants
• Link to the study website

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2021
• Primary Completion (Anticipated): May 31, 2022
• Study Completion (Anticipated): May 31, 2022

Study Registration Dates

• First Submitted: December 31, 2020
• First Submitted That Met QC Criteria: December 31, 2020
• First Posted (Actual): January 5, 2021

Study Record Updates

• Last Update Posted (Actual): February 16, 2022
• Last Update Submitted That Met QC Criteria: February 15, 2022
• Last Verified: February 1, 2022

More Information

Terms related to this study

• Keywords: Sick leave, sickness absence, shift work, quick returns
• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Dyssomnias; Neurologic Manifestations; Occupational Diseases; Chronobiology Disorders; Sleep Wake Disorders; Sleep Disorders, Circadian Rhythm
• Other Study ID Numbers: 303671

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Yes
• IPD Plan Description: De-identified data that underlie the results reported from the trial described in this protocol will be available to researchers from accredited research institutions. Access to data will be limited to investigators who provide a methodologically sound proposal and will be limited to a specified time period (commencing about 3 months after publication of a respective Article and ending after 5 years). To ensure compliance with the General Data Protection Regulation, data processing must be covered by the European Commission's standard contractual clauses for the transfer of data, which must be signed by the data requesters. Proposals and requests for data access should be directed to the corresponding author of the respective Article. User-friendly output from the trial will be disseminated to stakeholder and other relevant organisations.
• IPD Sharing Time Frame: De-identified data that underlie the results reported from the trial described in this protocol will be available to researchers from accredited research institutions. Access to data will be limited to investigators who provide a methodologically sound proposal and will be limited to a specified time period (commencing about 3 months after publication of a respective Article and ending after 5 years).
• IPD Sharing Access Criteria: To ensure compliance with the General Data Protection Regulation, data processing must be covered by the European Commission's standard contractual clauses for the transfer of data, which must be signed by the data requesters. Proposals and requests for data access should be directed to the corresponding author of the respective Article.
• IPD Sharing Supporting Information Type: Study Protocol; Statistical Analysis Plan (SAP); Informed Consent Form (ICF)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No